Onconetix (ONCO) Institutional Ownership $3.71 +0.03 (+0.82%) Closing price 04:00 PM EasternExtended Trading$3.71 0.00 (0.00%) As of 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Onconetix (NASDAQ:ONCO)CurrentInstitutional OwnershipPercentage23.89%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$118.50MNumber ofInstitutional Sellers(last 12 months)0 Get ONCO Insider Trade Alerts Want to know when executives and insiders are buying or selling Onconetix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Onconetix Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Millennium Management LLC39,477$25K0.0%N/A0.476% 2/12/2025Geode Capital Management LLC55,418$35K0.0%N/A0.668% 11/14/2024Zurcher Kantonalbank Zurich Cantonalbank 562,691$2.93M0.0%+83.8%76.039% 7/29/2024Zurcher Kantonalbank Zurich Cantonalbank306,079$51K0.0%N/A1.371% (Data available from 1/1/2016 forward) ONCO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ONCO shares? During the previous two years, the following institutional investors and hedge funds held shares of Onconetix shares: Zurcher Kantonalbank Zurich Cantonalbank ($2.93M), and Geode Capital Management LLC ($35K), Millennium Management LLC ($25K).Learn more on Onconetix's institutional investors. What percentage of Onconetix's stock is owned by institutional investors? 23.89% of Onconetix's stock is owned by institutional investors. Learn more on ONCO's institutional investor holdings. Which institutional investors have been buying Onconetix's stock? The following institutional investors have purchased Onconetix's stock in the last 24 months: Zurcher Kantonalbank Zurich Cantonalbank ($562.69K), Geode Capital Management LLC ($55.42K), and Millennium Management LLC ($39.48K). How much institutional buying is happening at Onconetix? Institutional investors have bought a total of 351,507 shares in the last 24 months. This purchase volume represents approximately $118.50M in transactions. Related Companies FBLG Major Shareholders APLM Major Shareholders HOTH Major Shareholders SYBX Major Shareholders EDSA Major Shareholders BLRX Major Shareholders CMMB Major Shareholders THAR Major Shareholders ASBP Major Shareholders TRAW Major Shareholders This page (NASDAQ:ONCO) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | Sponsored2 Nobel Prize winners warn of once-in-a-generation wealth shift…An unstoppable force is reshaping America — one so powerful it’s already disrupting how we work, invest, and l...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconetix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Onconetix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
